Results 281 to 290 of about 106,245 (320)
Some of the next articles are maybe not open access.
The Indian Journal of Pediatrics, 1996
Incidence of systemic candidiasis is increasing with improvement in the survival of high risk neonates who undergo multiple interventions. Therapies available to treat systemic fungal infection are few and have several drawbacks. Fluconazole, a new triazole derivative may be a useful anti-fungal agent in view of its excellent oral absorption, easy ...
Praveen Kumar +2 more
openaire +3 more sources
Incidence of systemic candidiasis is increasing with improvement in the survival of high risk neonates who undergo multiple interventions. Therapies available to treat systemic fungal infection are few and have several drawbacks. Fluconazole, a new triazole derivative may be a useful anti-fungal agent in view of its excellent oral absorption, easy ...
Praveen Kumar +2 more
openaire +3 more sources
Fluconazole for Cryptococcal Meningitis
Annals of Internal Medicine, 1989Excerpt The therapy for cryptococcal meningitis in patients with the acquired immunodeficiency syndrome (AIDS) is still unsatisfactory.
R. Esposito, C. U. Foppa, S. Antinori
openaire +4 more sources
Fluconazole prophylaxis in neonates
Archives of Disease in Childhood, 2014Progressive changes in clinical practice have improved the survival of even the most vulnerable neonates, such as those born preterm or with a very low birth weight (VLBW). Frequent contacts with healthcare workers, invasive procedures, early exposure to large scale antibiotics and immature immune systems, however, can cause additional, healthcare ...
Maurizio Bonati +7 more
openaire +3 more sources
Desensitization for fluconazole hypersensitivity
Journal of Allergy and Clinical Immunology, 1996These results are very similar to the M I D (approximate ly 0.5) de te rmined for o ther diseasespecific quality of life ques t ionnaires that use 7-point response opt ions (e.g., as thma, pediat r ic as thma, chronic respi ra tory disease, hear t failure).
Jagadish Boggavarapu +2 more
openaire +2 more sources
Fluconazole-Carbamazepine Interaction
Southern Medical Journal, 2002The patient we describe had elevated carbamazepine serum concentrations during concomitant fluconazole administration (400 mg/day), including serial concentrations both before and after antifungal therapy. Since fluconazole is a known inhibitor of the cytochrome P450 enzyme system, this suggests an inhibition of carbamazepine metabolism.
Christopher K, Finch +2 more
openaire +2 more sources
Diagnostic Microbiology and Infectious Disease, 2003
Two patients with renal failure and fluconazole resistant but flucytosine susceptible Candida deep infection were successfully treated with the combination of the two drugs. In vitro susceptibility, determined by microdilution and time-kill methods, and fungostatic activity of the serum showed an additive interaction of fluconazole and flucytosine.
Corrado Girmenia +2 more
openaire +4 more sources
Two patients with renal failure and fluconazole resistant but flucytosine susceptible Candida deep infection were successfully treated with the combination of the two drugs. In vitro susceptibility, determined by microdilution and time-kill methods, and fungostatic activity of the serum showed an additive interaction of fluconazole and flucytosine.
Corrado Girmenia +2 more
openaire +4 more sources
Contemporary Organic Synthesis, 1996
AbstractChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 100 leading journals. To access a ChemInform Abstract of an article which was published elsewhere, please select a “Full Text” option. The original article is trackable via the “References” option.
openaire +3 more sources
AbstractChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 100 leading journals. To access a ChemInform Abstract of an article which was published elsewhere, please select a “Full Text” option. The original article is trackable via the “References” option.
openaire +3 more sources
Spectral characterization of fluconazole
Journal of Pharmaceutical and Biomedical Analysis, 1996Reference 1H, 19F and 13C NMR, mass, IR and Raman spectra are provided to the open literature for the first time for the potent antifungal agent fluconazole, alpha-(2,4-difluorophenyl)-alpha-(1H-1,2,4-triazol-1-ylmethyl++ +)-1H-1,2, 4-triazole-1-ethanol. The 1H, 19F and 13C NMR spectra were analyzed in detail to attribute shifts, including 19F chemical
Brian Dawson +3 more
openaire +3 more sources
Journal of the American Medical Association (JAMA), 2016
IMPORTANCE Vaginal candidiasis is common during pregnancy. Although intravaginal formulations of topical azole antifungals are first-line treatment for pregnant women, oral fluconazole is often used despite limited safety information.
D. Mølgaard‐Nielsen +4 more
semanticscholar +1 more source
IMPORTANCE Vaginal candidiasis is common during pregnancy. Although intravaginal formulations of topical azole antifungals are first-line treatment for pregnant women, oral fluconazole is often used despite limited safety information.
D. Mølgaard‐Nielsen +4 more
semanticscholar +1 more source
Fluconazole (Diflucan®): a review
International Journal of Antimicrobial Agents, 1993Fluconazole is a triazole antifungal agent available for oral or intravenous use in the treatment of a number of localized and disseminated mycoses. Animal models have shown in vivo activity against infections caused by Candida spp. and Crytococcus neoformans.
Françoise Meunier, Mark Zervos
openaire +2 more sources